MustGrow Sees Positive Results From Greenhouse Trials Against Root Rot Disease

MustGrow Biologics (CSE: MGRO) this morning reported the results of greenhouse trials with its mustard-derived biopesticide known as TerraMG. Trials were conducted via an independent third party to determine the effectiveness of the formulation against aphanomyces euteiches, which is more commonly known as root rot.

Within the greenhouse trials, plants that were treated with MustGrow’s formulation reportedly demonstrated robust plant and root system health. The disease was found to be controlled by the biopesticide along a range of what have been deemed to be economic application rates.

Soil samples were initially infested with the disease prior to the application of the product. Those plants that were treated with TerraMG reportedly demonstrated increasingly robust results in line with application rates.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

The company will now continue to advance the trials of the formulation via larger scale field tests. Field testing, as previously announced, is being conducted with that of NexusBioAg under a collaboration arrangement.

MustGrow Biologics last traded at $1.75 on the CSE.


FULL DISCLOSURE: MustGrow Biologics Corp is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover MustGrow Biologics Corp on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Goliath Extends Golden Gate Lode 130 Metres With 13.45 g/t Gold Equivalent Over 4.85 Metres

Questcorp Begins 600 Metre Phase 2B Drill Program at La Union

Related News

MustGrow Biologics Updates Market On Its Biopesticide Product Pipeline

MustGrow Biologics (CSE: MGRO) this morning provided an update to the market on the status...

Wednesday, December 9, 2020, 07:22:59 AM

MustGrow Sees Executive From Impossible Foods Appointed To Board

MustGrow Biologics (CSE: MGRO) this morning had a major announcement, in that it has appointed...

Monday, December 14, 2020, 07:25:26 AM

MustGrow Biologics Sees Continued Positive Results From Field Trials For Banana Panama Disease

MustGrow Biologics (CSE: MGRO) has finally seen the results of its initial field trial program...

Wednesday, November 10, 2021, 08:01:52 AM

MustGrow Biologics Receives $1.5 Million From Exercise Of Warrants

MustGrow Biologics (CSE: MGRO) issued a brief news release this morning, indicating that it has...

Thursday, January 14, 2021, 07:57:13 AM

Curing The Banana Panama Disease – The Daily Dive feat Colin Bletsky of MustGrow Biologics

Kickstarting our short holiday week for the Daily Dive is that of Colin Bletsky, COO...

Monday, December 21, 2020, 01:00:00 PM